Gapping up
In reaction to strong earnings/guidance:
- HIMX +4.6%, STZ +4.6%, PLAY +3.9%
Other news:
- FATE +21% (announces first patient for FT596; also announces global collaboration deal with JNJ unit)
- TSLA +16.2% (provides Q1 production update)
- SVRA +11.8% (exclusive lic/collaboration agreement with GRFS for Apulmiq)
- EBS +9.9% (to partner with US govt for plasma-derived therapy for COVID-19 patients)
- HUYA +9.5% (announces Tencent's (TCEHY) exercise of its option and changes to board composition)
- MTL +4.8% (sales network Mechel Service is supplying steel rolls for construction of infectious disease hospitals designed to fight coronavirus all over Russia)
- NP +4.7% (announces that the Vectorply acquisition has not been completed)
- CAKE +2.6% (provides comp guidance)
- DVAX +2.6% (withdraws FY20 guidance for HEPLISAV-B net product sales)
- UPWK +2.6% (attributed to block trade)
- CODI +2.2% (provides COVID update)
- TEN +1.7% (provides business update regarding COVID-19)
- SUN +1.4% (maintains quarterly dividend)
Analyst comments:
- TWTR +4.3% (upgraded to Buy from Neutral at Goldman)
- UAA +2.7% (upgraded to Neutral from Sell at B. Riley FBR)
- XP +1.2% (upgraded to Buy from Neutral at Citigroup)